knowledge -WSS

knowledge

author：comprehensive 2025-10-02 07:01:29 - browse：85256

Novo Nordisk headquarters -- health coverage from STAT — LISELOTTE SABROE/Scanpix/AFP via Getty Images

The release of Novo Nordisk’s latest earnings report on Thursday provided a chance for executives to tout their major win this week — outcomes from a large trial showing the company’s obesity drug Wegovy cut the risk of heart complications by 20%.

But once again, much of the attention was focused on the company’s struggles to meet what Novo CEO Lars Fruergaard Jørgensen referred to as the “overwhelming demand for Wegovy.”

Jørgensen reiterated that the company was racing to expand supply and had brought on more contract manufacturing support, but Novo said Thursday that the company would continue to restrict the availability of lower-strength starter doses in the United States to ensure that patients on the drug would not have their medication interrupted.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Medicare details structure of new drug price negotiation program
Next article： An outdated Medicare rule harms dementia patients with anxiety

knowledge

WSS

Readout Newsletter: Merck, J&J, and long Covid

STAT wants to know your pick for a great summer read or listen

How CO2 helps viruses stay alive longer in the air

The surgeon had a dilemma only a Nazi medical text could resolve

FDA clears AI tool for detecting skin cancer

ASCO Daily Recap: CAR

focus

knowledge

hotspot

Guidelines to prevent youth baseball injuries need more muscle

'Little Tech' descents on D.C., wanting a say in how AI is regulated

Activists slam private health insurers over coverage restrictions

Francis Collins on trust in science and how Covid communications failed

Affirmative action in medical school literally saved lives

Data don't support strong claims for Covid

United colonoscopy coverage change 'may cost lives,' doctors say

Delfi Diagnostics unveils key aspects of liquid biopsy test for lung cancer

At least 13 dead in Texas as scorching temps continue

Fight over Supreme Court dialysis ruling puts kidney patients at risk

explore

The surgeon had a dilemma only a Nazi medical text could resolve

Senators tussle over abortion against the backdrop of a presidential campaign

Readout Newsletter: BridgeBio, Madrigal, and Silicon Valley Bank

The tragedy of Johnson & Johnson’s Covid vaccine

Readout LOUD podcast: Biotech layoffs, stock slump, 2024 preview

Test for long Covid? Researchers find new clue in blood samples

entertainment

knowledge

Wikipedia

hotspot